The dermatologist's quiet favorite finally went mainstream in 2024–2025. A naturally-occurring dicarboxylic acid (from grains; cosmetically synthesized) that simultaneously addresses acne, rosacea, post-inflammatory hyperpigmentation, and barrier inflammation — with a pregnancy-safe profile that few actives can match. The Ordinary 10%, Paula's Choice 10% Booster, and Naturium 10% turned a prescription molecule (15–20% Finacea/Azelex) into the most-recommended OTC active in dermatology TikTok. Tyrosinase inhibition + anti-microbial + anti-keratinization in a single, calm molecule.
Benefits
tyrosinase inhibition fades PIH and melasma without retinoid-grade irritation
anti-inflammatory and antibacterial — works on inflammatory acne and rosacea papules
pregnancy- and breastfeeding-safe (one of the few actives that is)
Example uses
PIH and melasma serums
rosacea-friendly daily treatments
pregnancy-safe acne care
Mechanism of action
A nine-carbon saturated dicarboxylic acid acting through at least four mechanisms: competitive inhibition of mitochondrial oxidoreductase in hyperactive melanocytes (selective for dysregulated cells — why it fades PIH without depigmenting normal skin), reversible tyrosinase inhibition, ROS scavenging via the dicarboxylic structure, and direct antimicrobial activity against Cutibacterium acnes via intracellular pH disruption. Anti-inflammatory action via kallikrein-5 and cathelicidin downregulation explains its rosacea efficacy.
Clinical evidence · High
FDA- and EMA-approved as a prescription drug (15–20%) for acne, rosacea, and melasma with extensive RCT support; OTC cosmetic 10% formulations have weaker but real evidence.
Tricky to formulate at high % in elegant textures — pure azelaic acid is gritty and pH-sensitive. Suspensions (The Ordinary's 10% cream-gel) trade elegance for efficacy; potassium azeloyl diglycinate is a more soluble derivative used by clean brands for serums but is meaningfully less proven. Optimal pH 4–5. Pairs well with niacinamide and azelaic-derivative peptides; avoid stacking with strong AHAs in the same routine.
Watchouts
Initial tingling and transient redness for 1–2 weeks is normal. Derivative forms (azeloyl glycine, potassium azeloyl diglycinate) are gentler but lack the clinical data of true azelaic acid.
The pregnancy-safety positioning is genuine and one of the few cosmetic actives with that profile. The recurring controversy is regulatory: in the US, OTC azelaic acid sits in a grey zone (drug vs cosmetic) that limits how brands can describe it. Derivative forms (potassium azeloyl diglycinate, azeloyl glycine) are softer-feeling but lack the dose-response data of the parent acid — the gap is widely papered over.
Market positioning
Once dismissed as the 'gritty one' next to glycolic and retinol, now repositioned as the multitasker for the inclusive-derm era — pregnancy, melanin-rich skin, rosacea, hormonal acne all addressed by one molecule. The reality slightly exceeds the marketing for once.